Evidence map›Paper›PMID 30955155›Full record

ArticleJournal of nephrology2019

Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study.

Hiroyuki Kiriyama, Hidehiro Kaneko, Hidetaka Itoh, Yuriko Yoshida, Koki Nakanishi, Yoshiko Mizuno, Masao Daimon, Hiroyuki Morita, Yutaka Yatomi, Issei Komuro

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hiroyuki KiriyamaThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Hidehiro KanekoThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan. kanekohidehiro@gmail.com.
Hidetaka ItohThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Yuriko YoshidaThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Koki NakanishiThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Yoshiko MizunoThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Masao DaimonThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Hiroyuki MoritaThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Yutaka YatomiThe Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
Issei KomuroThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPUniversity of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRisk factors for renal function deterioration in the general population are not fully understood. We aimed to clarify the determinants of estimated glomerular filtration rate (eGFR) decline using a community-based cohort. METHODS AND

resultsAmong 3217 subjects who underwent repeated health check-ups, we excluded 478 subjects with eGFR ≤ 60 mL/min/1.73 m

conclusionAnemia and proteinuria were closely related to eGFR decline, which suggests that we should consider these parameters as risk factors of the development of renal function deterioration even in the general population.

Indexed as

Glomerular Filtration RateAgedAnemiaCohort StudiesDisease ProgressionFemaleHumansJapanKidneyKidney DiseasesMaleMiddle AgedProteinuriaAnemiaeGFR declineProteinuria

Identifiers

PMID30955155
OpenAlexW2932975941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.